Patients: physical or psychiatric condition which may put the patient at risk, may confound the trial results or may interfere with the patient's participation in this trial; abuse of medication, drugs or alcohol; major depression (PHQ-9 score >/=23), acute suicidality, life expectancy <6 months at T0; already receiving another psychotherapeutic trauma therapy such as EDMR or CBT at T0; any neuroleptic, anticholinergic or anti-epileptic drugs 2 weeks prior to baseline; GPs: > 80% of patients with a specific mental condition